Combined Apheresis for ABO-incompatible Transplantation - a Pilot Study
Semiselective Immunoadsorption and Membrane Filtration for Desensitization in ABO-incompatible Kidney Transplantation - a Phase 2 Pilot Study
Sponsor: Elisabethinen Hospital
Terminated
Slow enrollment
Other terminated trials from Elisabethinen Hospital
A NA clinical study on Antibody-mediated Rejection and Decreased Immunologic Activity, this trial is terminated or withdrawn. The trial is conducted by Elisabethinen Hospital and has accumulated 9 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Sep 2022 — Jul 2024 [monthly]
Terminated NA
Status: Suspended → Terminated
-
Mar 2021 — Sep 2022 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Recruiting NA
Phase: PHASE2 → NA
-
Sep 2019 — Oct 2020 [monthly]
Recruiting PHASE2
-
Jun 2018 — Sep 2019 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Elisabethinen Hospital
- Medical University of Vienna
For direct contact, visit the study record on ClinicalTrials.gov .